本文選題：腎臟 + 透明細(xì)胞癌　； 參考：《山東大學(xué)》2017年碩士論文

【摘要】：目的腎透明細(xì)胞癌是目前腎臟最多見的腫瘤,CT是診斷的最主要的方式,因此對其影像學(xué)特點進行總結(jié)分析具有重要的原因。本研究主要分析腎透明細(xì)胞癌的多個CT特征,并對其臨床意義進行探討。Methods對39例(女16例,男23例,平均年齡54.6±12歲,范圍在26-.77歲之間)經(jīng)病理證實為腎透明細(xì)胞癌并行CT掃描的患者進行回顧性分析,對C T的多個表現(xiàn)進行總結(jié)同時探討其診斷價值,包括病灶大小、形狀(規(guī)則或不規(guī)則)、位置、邊緣清晰與否、有無鈣化、壞死、動靜脈畸形、轉(zhuǎn)移等,還包括強化類型、強化程度及強化曲線等,強化類型分為均勻和不均勻兩種,強化程度分為輕、中、顯著強化,強化曲線分為3型。同時探討各CT表現(xiàn)的之間的關(guān)系。另外,根據(jù)腫瘤的強化程度將其分為乏血管組和富血管組。Resu1ts病灶的大小與不規(guī)則的形狀、至少侵及腎臟的2/3,壞死及Ⅲ型強化曲線、動靜脈瘺有關(guān)(P0.05),富血管的透明細(xì)胞癌與更多壞死、不均勻強化及Ⅰ和Ⅱ型強化曲線相關(guān)(P0.05)。同時,邊緣模糊的病灶多傾向于Ⅰ型和Ⅱ型曲線(P0.05),不規(guī)則病變發(fā)生動靜脈瘺的幾率更高(P0.05)。腫瘤的轉(zhuǎn)移則與不均勻強化和壞死病灶更具相關(guān)性(P0.05).結(jié)論 CT is an effective imaging modality in the diagnosis and assessment of renal clear cell carcinoma,CT是診斷和評估腎透明細(xì)胞癌重要的成像技術(shù),可為腎透明細(xì)胞癌的診斷和治療提供更為精準(zhǔn)的信息。
[Abstract]:Objective clear cell carcinoma of kidney is the most common tumor in kidney at present, CT is the most important way to diagnose it, so it is important to summarize and analyze its imaging features. The purpose of this study was to analyze the CT features of renal clear cell carcinoma (RCC), and to explore its clinical significance in 39 cases (16 females, 23 males, mean age 54.6 鹵12 years). Patients with renal clear cell carcinoma confirmed pathologically by pathology and CT scan were retrospectively analyzed. The multiple manifestations of CT were summarized and the diagnostic value, including the size of the lesion, was discussed. Shape (regular or irregular, position, clear edge, calcification, necrosis, arteriovenous malformation, metastasis, etc.), as well as enhancement type, enhancement degree and enhancement curve, etc. The degree of enhancement is light, medium, significant, and the strengthening curve is divided into 3 types. At the same time, the relationship between CT findings was discussed. In addition, according to the degree of enhancement of the tumor, the tumor was divided into two groups: the size and irregular shape of the tumor in the absence of vessel group and the vascular rich group, and at least 2 / 3 of the kidney, necrosis and type 鈪，

本文編號：1998174